Fees in Respect of Drugs and Medical Devices Order

Marginal note:Remission — designated COVID-19 drug

• 14.1 (1) Remission is granted to the person referred to in subsection 9(2) of the amount of the fee that is payable under subsection 9(1) if the person has

  • (a) filed, under the ISAD Interim Order, an application for a designated COVID-19 drug, as defined in section C.08.001.1 of the Food and Drug Regulations as that section read immediately before the day on which subsection 24(1) of the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Agile Licensing) comes into force; and

  • (b) subsequently filed a submission for that drug.

• Marginal note:Remission — no previous submission

  (2) The remission referred to in subsection (1) is granted if the person has not previously filed a submission for that designated COVID-19 drug.